About OpenDNA
OpenDNA is a healthcare AI company focused on revolutionizing disease prevention and personalized medicine through the integration of advanced genomic analysis, clinical data, and artificial intelligence. Their platform processes millions of DNA bases, biomarkers, and clinical data points using proprietary AI frameworks, including machine learning and deep learning algorithms. This technology allows for the prediction, prevention, and personalized treatment of diseases with strong genetic predispositions.
For physicians, OpenDNA’s platform provides clinically actionable and easily understandable insights by distilling complex genetic data. The system has undergone rigorous validation, including a dataset of over 500,000 patients and two clinical trials, one in partnership with the Mayo Clinic, which is also an investor. The platform seamlessly integrates with Electronic Medical Records (EMRs), enabling easy test ordering, automatic data entry, and the full integration of interactive dashboards. These interactive dashboards allow clinicians and patients to adjust risk factors in real-time to visualize the impact on lifetime risk, fostering patient engagement and shared decision-making.
OpenDNA offers various AI-driven risk assessment tools, including CardioRisk+ for cardiometabolic heart disease, CancerRisk+ for breast, colon, and prostate cancer, TotalRisk+ for comprehensive polygenic-monogenic cancer risk, and PolyRisk+ which spans eight major disease areas. These tests cover 30 indications, enabling full-body risk profiling across categories such as cardiometabolic, cancer, autoimmune, eye, respiratory, neurological, mental health, and women’s health conditions. The company’s mission is to empower healthcare providers and patients with actionable insights that drive personalized treatment and preventive care strategies, ultimately improving health outcomes and reducing healthcare costs.
Focus Areas
Business Intelligence
| Technology | OpenDNA's AI Engine integrates genomics and clinical data for disease prediction and prevention. It utilizes validated Polygenic Risk Scores (PRS) and proprietary AI models that combine PRS with clinical data (family history, lifestyle) to create dynamic risk profiles. The platform offers interactive 'What-If' Dashboards for clinicians and patients to adjust risk factors in real-time and see the impact on lifetime risk. It is designed for seamless integration with Electronic Medical Records (EMRs). |
What Physicians Need to Know
OpenDNA's platform is designed to seamlessly integrate into clinical workflows, providing automated data pull from EMRs and Gen AI-based decision support for real-time, actionable insights. Physicians can utilize interactive 'what-if' dashboards to engage patients in shared decision-making by demonstrating how adjusting risk factors impacts lifetime risk. The system empowers clinicians with clear, immediate insights, which is particularly beneficial for busy family doctors. OpenDNA's tools have shown to impact clinical decision-making in a significant percentage of cases, leading to increased patient awareness, education, and modifications in management plans, including new statin recommendations and lifestyle adjustments.
OpenDNA's patented platform is built for seamless integration into existing clinical workflows and EMR systems, facilitating automated data pull and providing interactive dashboards that can be shared with patients. They have also engaged in collaborations with institutions like Mayo Clinic for pilot clinical studies and Psifas (the Israeli National Initiative for Personalized Medicine) to develop AI models for predicting genetic risk for common diseases, enriching biobank data for future research.
Reviews & Opinions
Videos
News, demos, and interviews about OpenDNA.
Videos load interactively. If none appear, search YouTube for OpenDNA →
Press & Coverage
Frequently Asked Questions
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]